EXPERTS-ALS is a ground-breaking project that will provide a platform to test drugs rapidly for their potential to slow the progression of Amyotrophic Lateral Sclerosis (ALS, the commonest form of Motor Neuron Disease). This will be done at a pace and scale not previously possible using human signals suggesting clinical benefit

Although EXPERTS-ALS cannot prove that a drug does or does not have long-term benefit in MND, it will quickly identify the most promising candidate drugs to go forward into the larger clinical trials needed to test this.  

See here to learn how EXPERTS-ALS works in more detail, and here to view up-to-date study progress.